Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of linperlisib in relapsed and/or refractory peripheral T/NK-cell lymphoma
CTR20210333Phase 2Active
- Sponsor
- Yingli Pharma
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in peripheral T-cell lymphoma (PTCL), sponsored by Yingli Pharma. Started Mar 2021; status: active.
02
Drugs
linperlisib
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on CTR20210333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210333.